Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
Thu, 06.03.2025
aconnic AG
aconnic AG (ISIN: DE000A0LBKW6), Munich, plans to increase the share capital against cash with a volume of 9 million EUR and to issue a convertible bond with a volume of 9 million EUR to strengthen equity and reduce debt.
For the planned capital raise aconnic will issue around 7 million new shares. The placement is planned with a subscription pric [ … ]
Thu, 06.03.2025
Cliq Digital AG
Cliq Digital AG entered into a transaction framework agreement relating to a potential tender offer and is considering a subsequent share repurchase offer and delisting
Dusseldorf, March 6th, 2025 – Today, Cliq Digital AG ("Company") has entered into a transaction framework agreement with Dylan Media B.V. ("Dylan Media") relating to a potential pa [ … ]
Thu, 06.03.2025
Biotest AG
Ad hoc NOTICE
Notification pursuant to Art. 17 EU Market Abuse Regulation (MAR)
CFO Martin Möller to leave Biotest as planned at the end of his contract. Position of CFO to be filled in the near future
Dreieich, Germany, 6 March 2025. The Board of Management of Biotest AG announces that Chief Financial Officer Martin Möller will terminate his [ … ]
Thu, 06.03.2025
Geberit AG
Once again, an extremely challenging year is behind the Geberit Group. However, despite a strong decline in the building construction industry in Europe, sales and sales volumes were increased. The major success of the recently launched products on the market was very pleasing in this regard. Operating margins were only slightly below the previous [ … ]
Thu, 06.03.2025
Cicor Technologies Ltd
Ad hoc announcement pursuant to Art. 53 LR
Bronschhofen, 6 March 2025 - Cicor Group (SIX Swiss Exchange: CICN) today announces that the discussions with the company Éolane France and relevant governmental authorities regarding a potential acquisition of selected Éolane France businesses, as mentioned in Cicor's media statement of 22 January 2025, h [ … ]
Thu, 06.03.2025
Helvetia Holding AG
Ad hoc announcement pursuant to Art. 53 LR
St.Gallen, 6 March 2025
In 2024, Helvetia performed well thanks to its diversified business base.
Key figures of the 2024 annual financial statements are:
Underlying earnings grew 41.9% in 2024 to CHF 528.5 million (2023: CHF 372.5 million).
The Group's IFRS net income stood at CHF 502.4 million (20 [ … ]
Thu, 06.03.2025
Relief Therapeutics Holding SA
Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion
GENEVA (March 6, 2025) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced that discussi [ … ]
Thu, 06.03.2025
Cicor Technologies Ltd
Ad hoc announcement pursuant to Art. 53 LR
Bronschhofen, 6 March, 2025 – The Cicor Group (SIX Swiss Exchange: CICN) looks back on an exceptionally successful year 2024. Significant market share gains and steadily increasing profit margins at all levels demonstrate the consistent execution of Cicor’s strategy. Earnings per share rose to CHF 6.20 (20 [ … ]
Thu, 06.03.2025
Evolva Holding SA
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LREvolva publishes agenda for Annual General Meeting 2025
Reinach, Switzerland, 6 March 2025 — Evolva Holding SA (SIX: EVE) today published the agenda for its Annual General Meeting (AGM) to be held on Thursday, 27 March 2025 at 9.00 a.m. CET at Hotel Victoria in Basel, Switzerland.
The Boar [ … ]
Thu, 06.03.2025
Comet Holding AG
Ad hoc announcement pursuant to Art. 53 LRFull-year 2024
Net sales increased by 12.1% to CHF 445.4 million (FY23: CHF 397.5 million)
EBITDA margin of 13.6% compared to 11.3% in FY23
Return on capital employed (ROCE) at 10.4%, up from 6.6% in the previous year
Dividend increased by 50% to 1.50 CHF per share
Outlook for 2025
Spending on wafer [ … ]